CompuMed launches operation of TeleCor division for providing cardiac telemedicine monitoring service
MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–March 24, 1995– CompuMed Inc. (NASDAQ Small Cap:CMPD) today announced that TeleCor, its new business division for providing cardiac transtelephonic monitoring services to physicians and other healthcare providers, has begun operations.
TeleCor, which is a telemetry center servicing medical professionals, is part of CompuMed’s recently announced business venture to develop new cardiac telemedicine products and markets with Aerotel Ltd., a medical device and telecommunications company based in Holon, Israel.
The companies jointly presented the electrocardiogram (ECG) and cardiac outpatient monitoring products and services which TeleCor will offer at this week’s American College of Cardiology Conference in New Orleans, La.
“The availability of low-cost, faster computer platforms and internetworking capabilities have created an excellent opportunity to bring physicians, providers and patients together for timelier, higher-quality medical management,” said Rod N. Raynovich, president and chief executive officer of CompuMed. “TeleCor gives patients the security of having continuous telephone contact and providers the ability to offer more cost-effective diagnoses.”
At TeleCor, CompuMed’s technicians transtelephonically monitor signals from the cardiac event recorder, a device, worn by a patient, which can continuously monitor heart rates and rhythms to detect arrhythmias and other cardiac abnormalities.
When a patient initiates the signal, the data is sent to TeleCor. At TeleCor, it is analyzed by a certified telemetry technician, using interpretive medical software, and entered into TeleCor’s database. The information is then transmitted to the attending physician and, if necessary, to a CompuMed cardiology consultant. This technology was recently demonstrated at a news conference CompuMed hosted for the Government of Israel Economic Mission.
“This alliance benefits CompuMed, Aerotel, and most importantly, the patients who will receive TeleCor’s state-of-the-art cardiac telemedicine services,” said Gerry Stoch, Israel’s Economic Consul for the Southwestern United States. “With its combination of large customer bases, well-established marketing channels, and cutting-edge technologies, this project provides an excellent example of how companies in the United States and Israel can, through strategic alliances, mutually enhance their businesses.”
CompuMed has been a pioneer in the field of telemedicine, in which physicians are assisted in processing cardiac diagnostic test information through computerized telecommunications networks. The company, which currently provides transtelephonic (ECG) services to more than 1,600 physicians and institutions, expects to augment these services with the products to be provided by Aerotel, including the cardiac event recorder. Marketing for TeleCor will be handled by CompuMed’s exclusive sales, marketing and service organization, Medical Data Resources, which recently completed training of TeleCor’s sales and service force and began its sales efforts. In addition to TeleCor, CompuMed and Aerotel have also discussed plans for more cardiac monitoring products designed to build upon TeleCor’s customer base.
“The formation of TeleCor illustrates the exciting potential that the Aerotel alliance holds for expanding CompuMed’s cardiac telemedicine business into new areas,” said Raynovich. “With Aerotel’s cardiac event recorder technology, CompuMed is now able to expand into the home healthcare market, which will be beneficial to healthcare providers and medical centers that want to track patients outside medical facilities.
Aerotel, based in Holon, is a privately held company focused on cardiac medical devices and telecommunications. The company has product lines in electrophysiology and voice-signal processing. Aerotel markets its products in Europe, Asia and South America.
CompuMed, based in Manhattan Beach, is focused on providing solutions to important medical problems through the use of computer technology. In addition to its cardiac telemedicine business, the company currently markets the OsteoGram(R) service, a bone mineral density test which uses computer image analysis of simple hand x-ray to help physicians assess patient risk for osteoporosis. CompuMed is also developing Detoxahol(TM), a substance and delivery technology to facilitate the rapid reduction of blood alcohol levels in people who have been drinking.
CONTACT: CompuMed Inc., Manhattan Beach
Rod N. Raynovich, 310/643-5106 ext. 299
Noonan/Nusso Communications Inc., New York
Anthony J. Russo, 212/696-4455 ext. 202
Rich Tammero, ext. 222
COPYRIGHT 1995 Business Wire
COPYRIGHT 2004 Gale Group